Skip to content
Recall Observatory FDA recall evidence

Drug product

Temozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle (NDC 43975-253-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071.

D-0249-2019

October 05, 2018

Class III

Product summary

Firm
Amerigen Pharmaceuticals Inc.
Event
Event 81189
Status
Terminated
Classification
Class III
Quantity
5,232 bottles: a) 4,146 bottles; b) 1,086 bottles
Official record key
drug-enforcement:D-0249-2019

Official wording

Reason: Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.

Code information: Lot #: a) 17F058A, Exp 6/19; b) 17F058B, Exp 6/19

Distribution pattern: Product was distributed U.S. nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-Specification